Research Report for the year 2016

Scientific publications

Journal Articles:
  • Olivier CB, Schnabel K, Weber S, Zhou Q, Bode C, Moser M, Diehl P: Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel. J Thromb Thrombolys, 2016; 42: 84-89. :
  • Olivier CB, Weik P, Meyer M, Weber S, Anto-Michel N, Diehla P, Zhou Q, Geisen U, Bode C, Moser M: TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran. Thromb Res, 2016; 138: 63-68. :
  • Olivier CB, Weik P, Meyer M, Weber S, Diehl P, Bode C, Moser M, Zhou Q: Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors. J Thromb Thrombolys, 2016; 42: 161-166. :
  • Weber S, von Cube M, Sommer H, Wolkewitz M: Necessity of a competing risk approach in risk factor analysis of central line–associated bloodstream infection. Infect Cont Hosp Ep, 2016; 37: 1255-1257. :